Ad is loading...
CRSP
Price
$47.25
Change
+$0.40 (+0.85%)
Updated
Nov 15 closing price
92 days until earnings call
HALO
Price
$45.65
Change
-$8.31 (-15.40%)
Updated
Nov 15 closing price
99 days until earnings call
Ad is loading...

CRSP vs HALO

Header iconCRSP vs HALO Comparison
Open Charts CRSP vs HALOBanner chart's image
CRISPR Therapeutics AG
Price$47.25
Change+$0.40 (+0.85%)
Volume$3.13M
CapitalizationN/A
Halozyme Therapeutics
Price$45.65
Change-$8.31 (-15.40%)
Volume$7.23M
CapitalizationN/A
CRSP vs HALO Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRSP vs. HALO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongSell and HALO is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CRSP: $47.25 vs. HALO: $45.65)
Brand notoriety: CRSP and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 234% vs. HALO: 465%
Market capitalization -- CRSP: $4.03B vs. HALO: $5.81B
CRSP [@Biotechnology] is valued at $4.03B. HALO’s [@Biotechnology] market capitalization is $5.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while HALO’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • HALO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HALO is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -8.47% price change this week, while HALO (@Biotechnology) price change was -25.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

HALO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($5.81B) has a higher market cap than CRSP($4.03B). HALO YTD gains are higher at: 23.512 vs. CRSP (-24.521). HALO has higher annual earnings (EBITDA): 580M vs. CRSP (-335.17M). HALO has more cash in the bank: 666M vs. CRSP (484M). CRSP has less debt than HALO: CRSP (231M) vs HALO (1.5B). HALO has higher revenues than CRSP: HALO (947M) vs CRSP (200M).
CRSPHALOCRSP / HALO
Capitalization4.03B5.81B69%
EBITDA-335.17M580M-58%
Gain YTD-24.52123.512-104%
P/E RatioN/A15.12-
Revenue200M947M21%
Total Cash484M666M73%
Total Debt231M1.5B15%
FUNDAMENTALS RATINGS
CRSP vs HALO: Fundamental Ratings
CRSP
HALO
OUTLOOK RATING
1..100
699
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
9331
SMR RATING
1..100
9113
PRICE GROWTH RATING
1..100
7462
P/E GROWTH RATING
1..100
8588
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (63) in the Biotechnology industry is in the same range as HALO (77). This means that CRSP’s stock grew similarly to HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (31) in the Biotechnology industry is somewhat better than the same rating for CRSP (93). This means that HALO’s stock grew somewhat faster than CRSP’s over the last 12 months.

HALO's SMR Rating (13) in the Biotechnology industry is significantly better than the same rating for CRSP (91). This means that HALO’s stock grew significantly faster than CRSP’s over the last 12 months.

HALO's Price Growth Rating (62) in the Biotechnology industry is in the same range as CRSP (74). This means that HALO’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (85) in the Biotechnology industry is in the same range as HALO (88). This means that CRSP’s stock grew similarly to HALO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPHALO
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 3 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
58%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSIL12.580.10
+0.80%
AdvisorShares Psychedelics ETF
FXF100.050.35
+0.35%
Invesco CurrencyShares® Swiss Franc
HYLB36.41-0.01
-0.03%
Xtrackers USD High Yield Corp Bd ETF
AFK15.66-0.01
-0.06%
VanEck Africa ETF
NUGT38.63-0.53
-1.35%
Direxion Daily Gold Miners Bull 2X ETF

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-15.40%
AXON - HALO
47%
Loosely correlated
-0.86%
CRSP - HALO
39%
Loosely correlated
+0.85%
BEAM - HALO
37%
Loosely correlated
-8.59%
AVTE - HALO
36%
Loosely correlated
-1.17%
NTLA - HALO
36%
Loosely correlated
-7.61%
More